We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+0.63%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.27B
AUM Growth
-$7.55M
Cap. Flow
-$219K
Cap. Flow %
-0.02%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$219K

Sector Composition

Rank Sector Weight
1 Healthcare 52.32%
2 Consumer Staples 29.37%
3 Miscellaneous 12.9%
4 Industrials 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$611M 48.01%
10,795,348
-4,062
-0% -$219K
MNST icon
2
Monster Beverage
MNST
$87.7B
$373M 29.37%
18,625,952
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$164M 12.9%
1,095,000
AXON
4
Axon Enterprise
AXON
$38.4B
$68.9M 5.42%
760,062
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$266M
$31.8M 2.5%
34,005,379
IMDX
6
Insight Molecular Diagnostics
IMDX
$125M
$20.5M 1.61%
735,810
SER icon
7
Serina Therapeutics
SER
$58.2M
$2.43M 0.19%
85,219

Similar funds

Broadwood Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Broadwood Capital held 7 positions worth $1.27B, down 0.59% from $1.28B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 57% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital's biggest Q3 2020 reduction was STAAR Surgical, cutting an estimated $219K.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.27B portfolio in Q3 2020.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2020.
  • Broadwood Capital's portfolio value fell 0.59% quarter-over-quarter to $1.27B.

Based on Broadwood Capital's 13F filing for Q3 2020, filed 16 Nov 2020.